Global General Anaesthetic Medication 麻豆原创 Research Report 2024

Publication ID:

PB507249672

Publication Date:

July 9, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The global General Anaesthetic Medication market was valued at US$ 3926 million in 2023 and is anticipated to reach US$ 4983.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
This report aims to provide a comprehensive presentation of the global market for General Anaesthetic Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthetic Medication.
Report Scope
The General Anaesthetic Medication market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anaesthetic Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anaesthetic Medication companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Anaesthetic Medication companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global General Anaesthetic Medication 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 麻豆原创 by Application
1.3.1 Global General Anaesthetic Medication 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anaesthetic Medication 麻豆原创 Perspective (2019-2030)
2.2 General Anaesthetic Medication Growth Trends by Region
2.2.1 Global General Anaesthetic Medication 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 General Anaesthetic Medication Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 General Anaesthetic Medication Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 General Anaesthetic Medication 麻豆原创 Dynamics
2.3.1 General Anaesthetic Medication Industry Trends
2.3.2 General Anaesthetic Medication 麻豆原创 Drivers
2.3.3 General Anaesthetic Medication 麻豆原创 Challenges
2.3.4 General Anaesthetic Medication 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anaesthetic Medication Players by Revenue
3.1.1 Global Top General Anaesthetic Medication Players by Revenue (2019-2024)
3.1.2 Global General Anaesthetic Medication Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global General Anaesthetic Medication 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anaesthetic Medication Revenue
3.4 Global General Anaesthetic Medication 麻豆原创 Concentration Ratio
3.4.1 Global General Anaesthetic Medication 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anaesthetic Medication Revenue in 2023
3.5 General Anaesthetic Medication Key Players Head office and Area Served
3.6 Key Players General Anaesthetic Medication Product Solution and Service
3.7 Date of Enter into General Anaesthetic Medication 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anaesthetic Medication Breakdown Data by Type
4.1 Global General Anaesthetic Medication Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global General Anaesthetic Medication Forecasted 麻豆原创 Size by Type (2025-2030)
5 General Anaesthetic Medication Breakdown Data by Application
5.1 Global General Anaesthetic Medication Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global General Anaesthetic Medication Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America General Anaesthetic Medication 麻豆原创 Size (2019-2030)
6.2 North America General Anaesthetic Medication 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America General Anaesthetic Medication 麻豆原创 Size by Country (2019-2024)
6.4 North America General Anaesthetic Medication 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anaesthetic Medication 麻豆原创 Size (2019-2030)
7.2 Europe General Anaesthetic Medication 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe General Anaesthetic Medication 麻豆原创 Size by Country (2019-2024)
7.4 Europe General Anaesthetic Medication 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anaesthetic Medication 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific General Anaesthetic Medication 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific General Anaesthetic Medication 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific General Anaesthetic Medication 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anaesthetic Medication 麻豆原创 Size (2019-2030)
9.2 Latin America General Anaesthetic Medication 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America General Anaesthetic Medication 麻豆原创 Size by Country (2019-2024)
9.4 Latin America General Anaesthetic Medication 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anaesthetic Medication 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa General Anaesthetic Medication 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa General Anaesthetic Medication 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa General Anaesthetic Medication 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Detail
11.1.2 Aspen Pharma Business Overview
11.1.3 Aspen Pharma General Anaesthetic Medication Introduction
11.1.4 Aspen Pharma Revenue in General Anaesthetic Medication Business (2019-2024)
11.1.5 Aspen Pharma Recent Development
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Detail
11.2.2 Fresenius-Kabi Business Overview
11.2.3 Fresenius-Kabi General Anaesthetic Medication Introduction
11.2.4 Fresenius-Kabi Revenue in General Anaesthetic Medication Business (2019-2024)
11.2.5 Fresenius-Kabi Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie General Anaesthetic Medication Introduction
11.3.4 AbbVie Revenue in General Anaesthetic Medication Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Detail
11.4.2 Baxter Healthcare Business Overview
11.4.3 Baxter Healthcare General Anaesthetic Medication Introduction
11.4.4 Baxter Healthcare Revenue in General Anaesthetic Medication Business (2019-2024)
11.4.5 Baxter Healthcare Recent Development
11.5 B.Braun
11.5.1 B.Braun Company Detail
11.5.2 B.Braun Business Overview
11.5.3 B.Braun General Anaesthetic Medication Introduction
11.5.4 B.Braun Revenue in General Anaesthetic Medication Business (2019-2024)
11.5.5 B.Braun Recent Development
11.6 Maruishi
11.6.1 Maruishi Company Detail
11.6.2 Maruishi Business Overview
11.6.3 Maruishi General Anaesthetic Medication Introduction
11.6.4 Maruishi Revenue in General Anaesthetic Medication Business (2019-2024)
11.6.5 Maruishi Recent Development
11.7 Piramal
11.7.1 Piramal Company Detail
11.7.2 Piramal Business Overview
11.7.3 Piramal General Anaesthetic Medication Introduction
11.7.4 Piramal Revenue in General Anaesthetic Medication Business (2019-2024)
11.7.5 Piramal Recent Development
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Detail
11.8.2 Hikma Pharmaceuticals Business Overview
11.8.3 Hikma Pharmaceuticals General Anaesthetic Medication Introduction
11.8.4 Hikma Pharmaceuticals Revenue in General Anaesthetic Medication Business (2019-2024)
11.8.5 Hikma Pharmaceuticals Recent Development
11.9 Yichang Humanwell
11.9.1 Yichang Humanwell Company Detail
11.9.2 Yichang Humanwell Business Overview
11.9.3 Yichang Humanwell General Anaesthetic Medication Introduction
11.9.4 Yichang Humanwell Revenue in General Anaesthetic Medication Business (2019-2024)
11.9.5 Yichang Humanwell Recent Development
11.10 Nhwa
11.10.1 Nhwa Company Detail
11.10.2 Nhwa Business Overview
11.10.3 Nhwa General Anaesthetic Medication Introduction
11.10.4 Nhwa Revenue in General Anaesthetic Medication Business (2019-2024)
11.10.5 Nhwa Recent Development
11.11 Hengrui
11.11.1 Hengrui Company Detail
11.11.2 Hengrui Business Overview
11.11.3 Hengrui General Anaesthetic Medication Introduction
11.11.4 Hengrui Revenue in General Anaesthetic Medication Business (2019-2024)
11.11.5 Hengrui Recent Development
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Detail
11.12.2 Xi'an Libang Business Overview
11.12.3 Xi'an Libang General Anaesthetic Medication Introduction
11.12.4 Xi'an Libang Revenue in General Anaesthetic Medication Business (2019-2024)
11.12.5 Xi'an Libang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.